1.42
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt LXRX?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        Lexicon Pharmaceuticals Inc Aktie (LXRX) Neueste Nachrichten
Is Lexicon Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Institutional & Consistent Profit Alerts - newser.com
What candlestick patterns are forming on Lexicon Pharmaceuticals Inc.Market Sentiment Review & Free High Return Stock Watch Alerts - newser.com
Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsQuarterly Profit Summary & Weekly High Return Forecasts - newser.com
Using data tools to time your Lexicon Pharmaceuticals Inc. exitJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Published on: 2025-10-24 01:54:11 - newser.com
Is Lexicon Pharmaceuticals Inc. building a consolidation baseDip Buying & Safe Swing Trade Setups - newser.com
Published on: 2025-10-21 14:44:52 - newser.com
Full technical analysis of Lexicon Pharmaceuticals Inc. stockEntry Point & Safe Entry Zone Tips - newser.com
What analysts say about Lexicon Pharmaceuticals Inc stockTrading Volume Trends & Double Or Triple Investment - earlytimes.in
Macro Review: Is Lexicon Pharmaceuticals Inc. stock a defensive play in 20252025 Market Overview & Comprehensive Market Scan Reports - nchmf.gov.vn
How analysts rate Lexicon Pharmaceuticals Inc. stock todayWeekly Trend Recap & Long-Term Growth Stock Strategies - nchmf.gov.vn
Activity Recap: How analysts rate Lexicon Pharmaceuticals Inc. stock todayJuly 2025 EndofMonth & Community Trade Idea Sharing - nchmf.gov.vn
Is Lexicon Pharmaceuticals Inc. stock a defensive play in 20252025 Pullback Review & AI Optimized Trading Strategy Guides - nchmf.gov.vn
Lexicon Pharmaceuticals Inc Stock Analysis and ForecastSector Leadership Analysis & Affordable Growth Strategies - earlytimes.in
Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit - The Manila Times
Lexicon Pharmaceuticals Advances 10mg Pilavapadin to Phase 3 | LXRX Stock News - Stock Titan
Short interest data insights for Lexicon Pharmaceuticals Inc.2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8% HigherWhat's Next? - MarketBeat
Lexicon Pharmaceuticals' (LXRX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Down 6.3%Time to Sell? - MarketBeat
Lexicon (LXRX) Engages in Policy Discussion to Tackle Chronic Pa - GuruFocus
Lexicon Pharmaceuticals Hosts Roundtable on Legislative Solutions for Chronic Pain Management - Quiver Quantitative
Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain - MarketScreener
Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People With Chronic Pain - 富途牛牛
Detecting price anomalies in Lexicon Pharmaceuticals Inc. with AIEarnings Beat & Intraday High Probability Alerts - newser.com
Can you recover from losses in Lexicon Pharmaceuticals Inc.2025 Analyst Calls & Safe Entry Point Identification - newser.com
Is Lexicon Pharmaceuticals Inc. a candidate for recovery playPortfolio Value Summary & Consistent Income Trade Recommendations - newser.com
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App
                